Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis.

Front Oncol · 2021 · PMC8187798 · PMID 34123863

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In a study to evaluate NMIBC response to BCG treatment, CyTOF was employed to observe a decreasing trend of T cell subsets in peripheral blood and corresponding tissue recruitment of immune cells in treated tumors ( 28 ), thus supporting the rationale of combining immunotherapy to overcome BCG resistance in NMIBC patients.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.